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        Introduction 
  Regulatory GTPases act as molecular switches that can rapidly 
interconvert between two conformational states, depending on 
whether GTP or GDP is bound. The cellular actions of GTPases 
are typically initiated by GTP binding, promoted by guanine nu-
cleotide exchange factors (GEFs), and terminated by GTP hy-
dro lysis that is facilitated by GTPase-activating proteins (GAPs). 
Within the Ras superfamily (  Wennerberg et al., 2005  ), com-
prised of   >  150 GTPases, each family (Ras, Rho, Rab, Arf, and 
Ran) uses distinct sets of GEFs and GAPs to regulate signaling. 
Though originally envisioned as simple   “  off switches  ”   in Arf 
signaling, the ArfGAPs have also emerged as effectors and 
key components in the assembly of nanomachines with complex 
signaling potential (  Gillingham and Munro, 2007  ;   Inoue and 
Randazzo, 2007  ). 
  ArfGAPs are a family of proteins containing a charac-
teristic module, the ArfGAP domain, which was fi  rst identi-
fi  ed in rat ArfGAP1 as the domain responsible for stimulation 
of GTP hydrolysis on Arf1 (  Cukierman et al., 1995  ). ArfGAP 
domains are ancient and highly conserved since the earliest 
eukaryotes. Five ArfGAPs have been identifi  ed in the yeast 
  Saccharomyces cerevisiae   and shown to display a combina-
tion of redundant and unique functions. Mammalian cells ex-
press an array of ArfGAPs ranging from relatively small proteins 
resembling those found in yeast to the large, multi-domain 
ArfGAPs that are proposed to function as scaffolds for cell 
signaling (  Fig. 1 A  ). 
  Structure, mechanism, and speciﬁ  city 
  ArfGAP domains are     130 amino acids in length and were 
originally defi  ned as the minimal fragment possessing ArfGAP 
activity (  Cukierman et al., 1995  ). They contain a characteristic C  4 -
type zinc fi  nger motif and a conserved arginine that is required 
for activity, within a particular spacing (CX  2 CX 16 CX 2 CX 4 R). 
The zinc fi  nger has an architectural rather than catalytic role 
(  Fig. 1 B  ) (  Goldberg, 1999  ). The invariant arginine was pro-
posed to serve in a catalytic   “  arginine fi   nger ”   mechanism,  simi-
lar to that found in GAPs for other GTPases, including Ras and 
Rho (  Scheffzek et al., 1998  ), and is highly exposed to solvent in 
the crystal structure (  Fig. 1 B  ).  
[ID]FIG1[/ID] However, the potential for other 
binding partners (e.g., coatomer;  Goldberg 1999 ) or other domains 
within some ArfGAPs (e.g., PH domains) serving supportive 
or regulatory roles in GAP-stimulated hydrolysis has also been 
demonstrated. For example, the ArfGAP activity of ASAP1 is 
dependent on the PH domain and is sensitive to PI(4,5)P  2 ,  and 
that of GITs is stimulated by PIP  3 . 
  ArfGAPs display various degrees of specifi  city for indi-
vidual members of the Arf family both in vitro and in live cells. 
However, these data are not easy to interpret due to uncertainties 
At the FASEB summer research conference on   “  Arf Family 
GTPases  ”  , held in Il Ciocco, Italy in June, 2007, it became 
evident to researchers that our understanding of the fam-
ily of Arf GTPase activating proteins (ArfGAPs) has grown 
exponentially in recent years. A common nomenclature 
for these genes and proteins will facilitate discovery of 
biological functions and possible connections to patho-
genesis. Nearly 100 researchers were contacted to gener-
ate a consensus nomenclature for human ArfGAPs. This 
article describes the resulting consensus nomenclature and 
provides a brief description of each of the 10 subfamilies 
of 31 human genes encoding proteins containing the Arf-
GAP domain.
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gests that the   “  canonical  ”   ArfGAPs, those containing the ArfGAP 
domain, may not represent the entire repertoire of proteins ca-
pable of stimulating GTP hydrolysis by Arf proteins. 
  Consensus nomenclature of the ArfGAP 
family of human genes and encoded proteins 
  Like most gene families today, gene/protein discovery and the 
accompanying nomenclature of ArfGAPs has come from a num-
ber of different laboratories and techniques and over a span of 
more than a decade. We have developed a consensus nomencla-
ture for the human ArfGAPs that is based upon the phylogeny 
of the ArfGAP domains and the domain organization of the pro-
teins, and updated or clarifi  ed the acronyms in use to more ac-
curately describe the current understanding of each protein.   Table I   
lists the consensus nomenclature for the human genes, previously 
published gene symbols and names, database identifi  ers, chromo-
some locations, and accession numbers. 
[ID]TBL 1[/ID]  These gene names 
should also be used for the encoded proteins, with appropriate 
in colocalization of the ArfGAP and Arfs in cells, incomplete 
knowledge of the importance of coregulators (lipids or other 
proteins), and because some ArfGAPs use their GAP domain to 
bind Arf without promoting GTP hydrolysis. For the most part 
(see below) ArfGAPs are active on one or more of the   “  true  ”   
Arfs (Arf1-6) but not on the Arf-like (Arl) or Sar proteins, which 
use distinct families of GAPs. Arf GAP activity has been demon-
strated in vitro for at least one member of each subfamily, with 
the exception of the ADAPs, which appear to lack in vitro GAP 
activity. However, overexpression of ADAP1 reduces activated 
Arf6 (but not Arf1) levels, and diminishes cortical actin and 
stress fi  bers, consistent with function as an Arf6 GAP. 
  Although ArfGAPs had been thought to distinguish be-
tween Arfs and Arls, Gcs1p (a yeast orthologue of mammalian 
ArfGAP1) was reported to function as GAP for both yeast Arf1p 
and Arl1p (  Liu et al., 2005  ). Conversely, Arl2 GAP isolated 
from bovine testis lacks the ArfGAP domain but exhibits GAP 
activity toward Arfs (  Bowzard et al., 2007  ). The latter fi  nding sug-
  Figure 1.       Domain organization of human ArfGAP subfamilies and structure of the ArfGAP domain.   (A) Representative domain structures of each 
human ArfGAP subfamily are depicted and are drawn to scale. Abbreviations are: ALPS, ArfGAP1 lipid-packing sensor; ArfGAP, ArfGAP domain; 
ANK, ankyrin repeat; BAR, Bin/Amphiphysin/Rvs; CALM, CALM binding domain; CB, clathrin-box; CC, coiled-coil; FG repeats, multiple copies of the 
XXFG motif; GLD, GTP-binding protein-like domain; PBS, Paxillin binding site; PH, pleckstrin homology domain; Pro(PxxP)3, cluster of three Proline-rich 
(PxxP) motifs; Pro(D/ELPPKP)8, eight tandem Proline-rich (D/ELPPKP) motifs; RA, Ras association motif; RhoGAP, RhoGAP domain; SAM, sterile     -motif; 
SH3, Src homology 3 domain; SHD, Spa-homology domain. Notes: (1) SMAP2 has CALM BD, but SMAP1 does not. (2) ASAP1 contains the indicated 
Pro-rich domains; ASAP2 and ASAP3 lack the Pro (D/ELPPKP) repeat and ASAP3 does not have an SH3 domain. (3) AGAP2 has a splice variant 
with three N-terminal PxxP motifs, called PIKE-L. (B) The structure of the isolated ArfGAP domain of human ArfGAP1 (residues 6  –  120) is displayed 
with the backbone shown in green with secondary structures indicated. The side chains of only the conserved arginine (Arg50, on the right) and the 
four zinc ﬁ  nger cysteines (center; Cys22, 25, 42, and 45) are displayed along with the coordinated Zn2+ (gray sphere). This image was generated 
using PyMol.     1041 NOMENCLATURE FOR THE HUMAN ARFGAPS PROTEINS    • Kahn et al. 
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  SMAP subfamily 
  SMAPs have been implicated as regulators of endocytosis and 
oncogenesis (  Tanabe et al., 2006  ). Human SMAPs are    50  kD 
and lack other defi  ned domains, thus the acronym small ArfGAP 
protein. The two human SMAP proteins share 47% identity 
overall, which rises to 83% identity in the ArfGAP domain. 
SMAPs bind to clathrin heavy chain via the clathrin binding 
motif (LLGLD) as well as the clathrin assembly protein, CALM 
(  Natsume et al., 2006  ). SMAP1 is cytosolic but is recruited to 
membranes where it regulates constitutive endocytosis. SMAP2 
is more stably bound to endosomes and is involved in the retro-
grade transport of TGN46 from early endosomes to the TGN 
(  Natsume et al., 2006  ). 
  AGFG subfamily 
  AGFG1 has been reported to be an essential HIV Rev cofactor, 
based on experiments that suggest that the ArfGAP domain 
mediates the release of Rev-directed HIV-1 RNAs from the peri-
nuclear region ( Sanchez-Velar et al., 2004 ). The Rev – AGFG1 
interaction is indirect and possibly bridged by the nuclear export 
receptor CRM1. The AGFG subfamily arose very early in eu-
karyotes, with a predicted progenitor in   G. lamblia   and  repre-
sentatives in molds, plants, fi  sh, and mammals. AGFG1 contains 
10 phenylalanine-glycine (FG) repeats, reminiscent of those 
found in nucleoporins. Thus, the AGFGs are ArfGAPs with FG 
repeats. Much less information is available on AGFG2. 
  GIT subfamily 
  GIT genes arose in animals and were duplicated in vertebrates. 
GIT2 expression is nearly ubiquitous, whereas GIT1 appears 
absent from many major cell types (muscle, hepatoctyes, pneu-
mocytes, adipocytes) but is especially prominent in endothelial 
cells (  Schmalzigaug et al., 2007  ). Unlike other ArfGAPs, GITs 
tightly associate with a specifi  c partner, the PIX/Cool proteins, 
to form oligomeric complexes (  Premont et al., 2004  ). PIX/Cool 
proteins are GEFs for Rac1 and Cdc42 GTPases. GIT/PIX com-
plexes function as scaffolds for a variety of signaling enzymes 
(including G protein receptor kinases, p21 activated kinases, fo-
cal adhesion kinases, MEK/Erk, and phospholipase C    ) and are 
recruited to distinct cellular locations via specifi  c partners (e.g., 
focal adhesions via paxillin or integrin    4, synapses via piccolo 
or liprin-    , and plasma membranes via scribble) (  Hoefen and 
Berk, 2006  ). GIT/PIX complexes function as sites of signal in-
tegration from multiple GTPase inputs, a feature shared by the 
ARAPs (see below). 
  ASAP subfamily 
  The ASAPs are associated with plasma membrane specializa-
tions (e.g., focal adhesions and invadopodia), and regulate as-
pects of endocytic traffi  c and actin remodeling (  Nie and Randazzo, 
2006  ;   Inoue and Randazzo, 2007  ;   Randazzo et al., 2007  ). ASAPs 
are found exclusively in animals, and have been duplicated in 
vertebrates, with three genes in humans that share multiple do-
mains (see   Fig. 1 A  ) but differ in their C termini. ASAP1 has 
tandem repeats of [D/ELPPKP] and an SH3 domain, ASAP2 
has an SH3 domain but no E/DLPPKP repeats, and ASAP3 has 
neither of these motifs. These differences at the C termini have 
indications when more than one splice variant is known to exist. 
The 31 predicted human ArfGAPs have been classifi  ed into 10 
subfamilies, based on sequence similarities of their ArfGAP do-
mains, and supported by the conservation of the domain ar-
chitecture within each subfamily (see   Fig. 1 A  ). The acquisition 
of additional domains throughout eukaryotic evolution has con-
tributed to the acquisition of new functions by different ArfGAPs. 
A brief summary of each subfamily is presented below. 
  ArfGAP1 subfamily 
  This founder of the ArfGAP family is also the smallest member, 
at     45 kD. ArfGAP1 shuttles between cytosol and the Golgi, 
where it is involved in regulating the COPI mechanism of mem-
brane traffi  c. The region of ArfGAP1 C-terminal to the ArfGAP 
domain is predicted to be largely unstructured. This region con-
tains two stretches, termed ALPS motifs, that have the propen-
sity in vitro to fold into amphipathic     -helices upon interaction 
with membranes that are highly curved or contain loosely packed 
lipids (  Bigay et al., 2005  ;   Mesmin et al., 2007  ), and are required 
for Golgi targeting of the protein in vivo (  Levi et al., 2008  ). The 
ALPS motifs are predicted to orient the protein on the mem-
brane and to contribute substantially to regulation of its activity 
in cells. ArfGAP activity is also regulated by the COPI coat com-
plex (  Goldberg, 1999  ). While most studies have focused on the 
role of ArfGAP1 in the COPI system, ArfGAP1 also interacts 
with components of clathrin coated carriers (including clathrin, 
AP-1, and AP-2), although the functional consequences of these 
interactions remains to be established. 
  ArfGAP2 subfamily 
  ArfGAPs 1  –  3 are predicted to have arisen from a common an-
cestor (e.g., a single gene is present in   G. lamblia  ) with an early 
split into distinctive ArfGAP1 and ArfGAP2 subfamilies and 
later duplications leading to the ArfGAP2/ArfGAP3 diver-
gence. Human ArfGAP2 and 3 are closely related proteins 
(58% identity) with little similarity to ArfGAP1 outside the cat-
alytic domain. ArfGAP1 and ArfGAP2/3 display functional 
interplay, as indicated by synthetic lethality observed between 
these ArfGAPs in HeLa cells (  Frigerio et al., 2007  ), and in 
  S. cerevisiae   (Gcs1 and Glo3;   Poon et al., 1999  ). ArfGAP2/3 lack 
ALPS motifs but are found on Golgi membranes as a result of 
strong interactions with the COPI coat (  Watson et al., 2004  ; 
  Frigerio et al., 2007  ). Like ArfGAP1, the GAP activities of Arf-
GAP2/3 are stimulated by coatomer (unpublished data). How 
each of these ArfGAPs contributes to the COPI mechanism re-
mains unclear. 
  ADAP subfamily 
  ADAP1 (ArfGAP with dual PH domains; previously centaurin 
   1, p42(IP 4 ), or PIP  3 BP) was identifi  ed as a high affi  nity PI(3,4,5)P  3  
and Ins(1,3,4,5)P  4   binding protein. ADAP1 is proposed to func-
tion as an Arf6 GAP that regulates the actin cytoskeleton, mem-
brane traffi  c, and neuronal differentiation (  Thacker et al., 2004  ; 
  Venkateswarlu et al., 2004  ). ADAP1 localizes to dendrites, spines, 
and synapses of developing and adult neurons and can impact 
traffi  c of regulated secretory vesicles in neuronal cells. Studies 
of ADAP2 have not been reported. 1043 NOMENCLATURE FOR THE HUMAN ARFGAPS PROTEINS    • Kahn et al. 
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led to confusion in nomenclature, but phylogenetic analysis of 
the ArfGAP domains supports the conclusion that these three 
ASAPs form a distinct group. 
  ASAP1 was identifi  ed as a Src-binding protein but also 
binds CrkL, focal adhesion kinase, CD2AP, and CIN85 (  Inoue 
and Randazzo, 2007  ). ASAP2 binds pyk2, a focal adhesion ki-
nase, whereas ASAP3 associates with focal adhesions and regu-
lates stress fi  bers (  Ha et al., 2008  ). 
  AGAP subfamily 
  AGAPs are present in animals only and there are 11 human genes 
predicted to encode AGAP-type proteins, arising from amplifi  ca-
tions in regions of human chromosome 10q, with a number of 
pseudo genes predicted in this same region. AGAPs possess a 
GTP-binding domain, reported to directly bind and activate 
Akt and other Ras effectors (  Ye and Snyder, 2004  ). AGAP2 
has multiple splice variants with one possessing an SH3 bind-
ing motif N-terminal to the GTP-binding protein-like domain. 
AGAP1 and AGAP2 have been the most extensively character-
ized members of this group. They function in the endocytic sys-
tem; AGAP1 working with AP-3 and AGAP2 with AP-1 (  Nie 
and Randazzo, 2006  ). 
  ACAP subfamily 
  ACAPs regulate Arf6-dependent actin remodeling and endo-
cytosis and receptor tyrosine kinase-dependent cell movement 
(  Inoue and Randazzo, 2007  ). ACAP1 functions as part of an Arf6-
regulated clathrin coat (  Li et al., 2007  ). ACAPs are found in   Dic-
tyostelium  and metazoans, with vertebrate duplications resulting 
in three human genes. ACAP is an acronym for ArfGAP with 
coiled coil, ankyrin repeat, and PH domains, though the coiled 
coil domain was later identifi  ed as a BAR domain. 
  ARAP subfamily 
  The presence of ArfGAP, RhoGAP, ankyrin repeats, and Ras 
association domains in ARAPs intimates that they are impor-
tant coordinators of two or more GTPase signaling pathways. 
Although the domain structures of the three ARAPs are similar, 
the proteins are distinct in functions and cellular locations with 
individual ARAPs showing different Arf, Rho, and Ras binding 
specifi  cities. Pathways affected by different family members 
include signaling through EGF receptor, focal adhesion dynam-
ics, and lamellipodia formation (  Inoue and Randazzo, 2007  ; 
  Randazzo et al., 2007  ). ARAPs are specifi  c to chordates, with 
three human genes. 
  Summary 
  ArfGAPs play critical roles in secretory and endocytic mem-
brane traffi  c as well as actin remodeling. Other ArfGAPs serve 
as scaffolds for cell signaling, allowing them to mediate cross-
talk between members of different GTPase families. Future 
studies aimed at dissecting ArfGAP functions and at identifying 
sources of specifi  city and regulation in their actions are certain 
to provide important insights into the role of ArfGAPs in cell 
physiology and in human pathologies. These outcomes should 
be facilitated by rapid adoption of the consensus nomenclature 
described herein. JCB • VOLUME 182 • NUMBER 6 • 2008  1044
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